Finance News – Nektar Therapeutics

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Stocks Investors Shares Stock Crypto Assets Cryptocurrency Stock Market Ethereum Price Markets Xrp Investment Stablecoin Blockchain Etf Sec Eth Bse Ipo Solana Index Trade Earnings Inflation Revenue Coinbase Interest Rates Token China Sensex Wall Street Nasdaq Federal Reserve Traders Treasury Gold Nse Bse Sensex Economy Usd Profit Tesla Sp 500 Trade War Digital Assets Royal Mail Act Revenue Office Q4 Loss Xpon Technologies Group Watchmakers Chip Deal Corporations Act Liquidation Engine Gfc Ceo Bonus

Filter by:

Past 24 hours
Past week
Past month
Past year

ABC News Business
BBC Business
Business Insider Markets
CBC Business
City A.M.
CNBC Business
CoinDesk
Cointelegraph
Crypto News
CryptoSlate
Decrypt
Economic Times Markets
Euronews Business
Financial Post Top Stories
Financial Times
Finextra Crypto
Finextra Market
Finextra Wealth
Globe and Mail Investing
Investing.com Global Markets
Investing.com Global Mkts
Investopedia
Kiplinger
MarketWatch MarketPulse
MarketWatch Top Stories
Quartz
Sky News Money
Sydney Morning Herald Biz
Sydney Morning Herald Business
TechCrunch Fintech
The Block
The Guardian – Business
WSJ Markets News

Nektar Therapeutics ×

Investopedia • Jun 24, 2025

Nektar Therapeutics Stock Doubles After Promising Eczema Drug Trial Results

The substantial increase in Nektar Therapeutics' share price reflects investor optimism following successful clinical trial outcomes for a new eczema treatment.

Read Full Article →